GE Healthcare Technologies On Track for Largest Percent Decrease Since April 2023 — Data Talk
GE Healthcare Technologies Inc. (GEHC) is currently at $87.68, down $4.14 or 4.51%
--Would be lowest close since Feb. 22, 2024, when it closed at $87.64
--On pace for largest percent decrease since April 25, 2023, when it fell 8.43%
--Currently down four of the past five days
--Currently down three consecutive days; down 6.59% over this period
--Worst three day stretch since the three days ending Nov. 29, 2023, when it fell 8.14%
--Down 3.94% month-to-date
--Up 13.4% year-to-date
--Down 6.59% from its all-time closing high of $93.87 on March 8, 2024
--Up 14.23% from 52 weeks ago (March 15, 2023), when it closed at $76.76
--Down 6.59% from its 52-week closing high of $93.87 on March 8, 2024
--Up 38.95% from its 52-week closing low of $63.10 on Oct. 27, 2023
--Traded as low as $86.55; lowest intraday level since Feb. 22, 2024, when it hit $85.00
--Down 5.74% at today's intraday low; largest intraday percent decrease since April 25, 2023, when it fell as much as 10.26%
--Second worst performer in the S&P 500 today
--Second worst performer in the Nasdaq 100 today
--Seventh most active stock in the Nasdaq 100 today
All data as of 10:44:25 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 13, 2024 11:01 ET (15:01 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks